In less than four decades, we have established five fully equipped manufacturing facilities to deliver exceptional drug quality across therapy segments, product formats and technologies. Our services such as on time delivery, quality products, services and regulatory support will always be available.
With all our facilities meeting GMP standards and gaining global regulatory approvals, we have now embarked on a mission to ensure sustainable practices by effecting several safety and environmental friendly initiatives.
Our In-house R&D infrastructure located at Uppal is equipped with an advanced synthetic chemistry laboratory and is ideal for process development and trouble shooting in the processes of existing product lines.
Our vast knowledge repository coupled with the access to latest in technology at this lab, we are well placed to deliver Cradle to Market realization for our customers. We carry out bench scale work at this lab and the data generated is utilized for scale up in the commercial batches.
This laboratory is also utilized for synthesis of process related impurities to support the analytical work.
Our R&D Lab also has the capability to further characterize and certify the impurity standards.
Our pilot plant (Kilo Lab), at Uppal is operational to translate the process capability from laboratory scale to “Kilo” stage before taking up commercial production.
All our three API manufacturing units located at Uppal (Unit I); Shamshabad (Unit III) and Bollaram (Unit IV) are US FDA certified and follow the highest standard of environmental safety processes.
Our Direct Compression Manufacturing Unit is located at Nacharam (Unit II).
Our Intermediaries manufacturing Unit is located at Solapur (Unit V).